Proton Therapy For
Thousands of men are diagnosed with Prostate cancer every year. It is one of the cancers where early detection and treatment can lead to positive results. In fact, there are 2 million prostate cancer survivors in the U.S. alone. Although treatment options should be determined according to each individual’s diagnosis, Proton Therapy is frequently considered to be an ideal treatment option for Prostate cancer. Our experienced physicians have successfully treated thousands of Prostate cancer patients using Proton Therapy.
How Proton Therapy Improves Prostate Cancer Treatment
Prostate tumors are notoriously resistant to radiation. The location of the prostate creates special treatment challenges because it is nestled between two of the most radiation-sensitive structures in the body; the bladder and rectum. This has traditionally created a difficult dilemma for radiation oncologists; high levels of radiation delivered to particularly sensitive areas of the body can cause discomfort and unwanted complications, but limiting radiation doses can prolong treatment and reduce its efficacy. However, the intense, focused radiation delivered by Proton Therapy meets and successfully addresses all of these challenges.
Unlike other treatments, Proton Therapy uses a concentrated beam of radiation that can be controlled with a very high degree of accuracy. It can deliver the maximal dose of radiation directly to the tumor while sparing surrounding tissues. This can translate into a reduced risk of the patient becoming incontinent or impotent.
To speak with our staff regarding the treatment of Prostate cancer, Click or Call +1-678-585-6608
Meet Dr. Sinesi
Dr. Christopher Sinesi is a highly experienced doctor with more than 27 years of practice in the field of oncology. He is highly regarded by his patients for his compassion and clinical excellence, as evidenced by the thousands he has cared for and treated during his career.
Our results indicated that Proton Beam Therapy monotherapy can be a beneficial treatment for localized Prostate Cancer. Furthermore, it can preserve the quality of life of these patients.Takeshi Arimura, Takashi Yoshiura, Kyoko Matsukawa, Naoaki Kondo, Ikumi Kitano, Takashi Ogino